Presentation Information

[JHG-3]SARS-CoV-2 genomic variations associated with mortality rate of COVID-20

Yujiro Toyoshima (Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan)